Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C0TU
|
|||
| Former ID |
DNCL003763
|
|||
| Drug Name |
SI-613
|
|||
| Indication | Knee osteoarthritis [ICD-11: FA01; ICD-9: 715] | Phase 2 | [1] | |
| Company |
SEIKAGAKU CORPORATION
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C58H79Cl2N5O35
|
|||
| Canonical SMILES |
CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)C(=O)NCCOC(=O)CC5=CC=CC=C5NC6=C(C=CC=C6Cl)Cl)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)C(=O)O)O)O)O)NC(=O)C)O)O)NC(=O)C)O)O
|
|||
| InChI |
1S/C58H79Cl2N5O35/c1-17(69)62-29-42(32(73)24(14-66)90-53(29)88)93-58-41(82)38(79)46(49(100-58)52(86)87)97-55-31(64-19(3)71)44(34(75)26(16-68)92-55)95-57-40(81)37(78)45(48(99-57)50(83)61-11-12-89-27(72)13-20-7-4-5-10-23(20)65-28-21(59)8-6-9-22(28)60)96-54-30(63-18(2)70)43(33(74)25(15-67)91-54)94-56-39(80)35(76)36(77)47(98-56)51(84)85/h4-10,24-26,29-49,53-58,65-68,73-82,88H,11-16H2,1-3H3,(H,61,83)(H,62,69)(H,63,70)(H,64,71)(H,84,85)(H,86,87)/t24-,25-,26-,29-,30-,31-,32-,33-,34-,35+,36+,37-,38-,39-,40-,41-,42-,43-,44-,45+,46+,47+,48+,49+,53-,54+,55+,56-,57-,58-/m1/s1
|
|||
| InChIKey |
SBQKIAATAMGBFR-NOWFGEBOSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036809) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.